نتایج جستجو برای: vrsa

تعداد نتایج: 217  

2015
Shankar Thangamani Waleed Younis Mohamed N. Seleem

Novel antimicrobials and new approaches to developing them are urgently needed. Repurposing already-approved drugs with well-characterized toxicology and pharmacology is a novel way to reduce the time, cost, and risk associated with antibiotic innovation. Ebselen, an organoselenium compound, is known to be clinically safe and has a well-known pharmacology profile. It has shown potent bactericid...

2015
Shankar Thangamani Manish Nepal Jean Chmielewski Mohamed N Seleem

The antibacterial activities and therapeutic efficacy of the cationic, unnatural proline-rich peptide Fl-P(R)P(R)P(L)-5 were evaluated against multidrug-resistant Staphylococcus aureus in a mouse model of skin infection. Fl-P(R)P(R)P(L)-5 showed potent activity against all clinical isolates of S. aureus tested, including methicillin- and vancomycin-resistant S. aureus (MRSA and VRSA, respective...

2011
Patrick D. Olson Lisa J. Kuechenmeister Kelsi L. Anderson Sonja Daily Karen E. Beenken Christelle M. Roux Michelle L. Reniere Tami L. Lewis William J. Weiss Mark Pulse Phung Nguyen Jerry W. Simecka John M. Morrison Khalid Sayood Oluwatoyin A. Asojo Mark S. Smeltzer Eric P. Skaar Paul M. Dunman

Methicillin-resistant Staphylococcus aureus is estimated to cause more U.S. deaths annually than HIV/AIDS. The emergence of hypervirulent and multidrug-resistant strains has further amplified public health concern and accentuated the need for new classes of antibiotics. RNA degradation is a required cellular process that could be exploited for novel antimicrobial drug development. However, such...

2013
Syeda Maria Naz Muhammad Usman Khan

Objective: This study was done to determine the sensitivity and resistance pattern to the most common antibiotics in use. Methodology: The data for this retrospective study was obtained and analysed from October 2010 to October 2011 in Lady Reading Hospital, Peshawar. Purposive sampling and univariate analysis was done. 2058 samples were cultured for sensitivity using Kirby Bauer's Diffusion te...

2016
D. Saravanan M. Radhakrishnan

In the present study, aqueous and solvent extracts of leaves collected from nine mangrove plants were screened against Methicillin resistant Staphylococcus aureus (MRSA), Vancomycin resistant Staphylococcus aureus (VRSA) and Extended spectrum beta lactamase (ESBL) strains. Out of nine mangrove plants Avicennia sp., Rhizophora sp., Ceriops decandra and Thillai species showed antimicrobial activi...

2010
K. Kosowska-Shick P. McGhee L. Beachel P. C. Appelbaum Peter C. Appelbaum

Revised) Materials and Methods (cont.) Dr. Peter C. Appelbaum Department of Pathology Hershey Medical Center 500 University Drive Hershey, PA 17033 Phone: (717) 531-5113 E-mail: [email protected] Background: We tested the ability of CEM-102 (sodium fusidate), an established antistaphylococcal drug, to select for resistant clones of 8 methicillin-resistant and 1 methicillin-susceptible S. aureu...

Journal: :Antimicrobial agents and chemotherapy 2010
C R Bourne E W Barrow R A Bunce P C Bourne K D Berlin W W Barrow

The bacterial burden on human health is quickly outweighing available therapeutics. Our long-term goal is the development of antimicrobials with the potential for broad-spectrum activity. We previously reported phthalazine-based inhibitors of dihydrofolate reductase (DHFR) with potent activity against Bacillus anthracis, a major component of Project BioShield. The most active molecule, named RA...

2015
Jennifer A. Johnson Eoin R. Feeney David W. Kubiak G. Ralph Corey

Oritavancin is a novel lipoglycopeptide with activity against Gram-positive organisms including streptococci, methicillin-resistant Staphylococcus aureus, vancomycin-resistant S aureus (VRSA), and vancomycin-resistant enterococci (VRE) [1-3]. The US Food and Drug Administration approved oritavancin as a single intravenous dose of 1200 mg for the treatment of acute bacterial skin and skin struct...

2012
Jamshid Faghri Delavar Shahbazzadeh Kamran Pooshang Bagheri Sharareh Moghim Hajieh Ghasemian Safaei Bahram Nasr Esfahani Hossein Fazeli Rahmatolah Yazdani Hamid Mirmohammad Sadeghi

OBJECTIVES Staphylococcus aureus is a foremost source of numerous nosocomial and community acquired infections. Antibiotic therapy for vancomycin resistant S. aureus (VRSA) can not promise the eradication of infections. Since adhesion is the major route of infections, adhesin based vaccine could suppress S. aureus infections. Fibronectin binding protein A (FnBPA) and clumping factor A (ClfA) ar...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید